Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Averett

Showing results (231-240 of 304) with videos related to

Pageof 31
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2009
Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistanceGeorge N Naumov, Monique B Nilsson, Tina Cascone, et al.
Genome Biology|October 13, 2001
Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridolL T Lam, O K Pickeral, A C Peng, et al.
Nature Reviews. Cancer|March 31, 2019
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model dataCharles M Rudin, John T Poirier, Lauren Averett Byers, et al.
Journal of Translational Medicine|November 24, 2022
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLCCarminia Maria Della Corte, Vincenza Ciaramella, Kavya Ramkumar, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 11, 2007
Discovery of ANA975: an oral prodrug of the TLR-7 agonist isatoribineAlan X Xiang, Stephen E Webber, Bradley M Kerr, et al.
Optics Express|April 7, 2017
Lasing of surface-polished polycrystalline Ho: YAG (yttrium aluminum garnet) fiberHyunjun Kim, Randall S Hay, Sean A McDaniel, et al.
Oncotarget|February 18, 2017
Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancerC Allison Stewart, Pan Tong, Robert J Cardnell, et al.
Ebiomedicine|March 16, 2024
Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancerSehhoon Park, Tae Hee Hong, Soohyun Hwang, et al.
Molecular Cancer Therapeutics|June 10, 2010
Serum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancerLauren Averett Byers, F Christopher Holsinger, Merrill S Kies, et al.
Science (New York, N.Y.)|January 11, 2000
Strange magnetism and the anapole structure of the protonR Hasty, A M Hawthorne-Allen, T Averett, et al.
Pageof 31

Showing results (231-240 of 304) with videos related to

Sort By:
Pageof 31
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2009
Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistanceGeorge N Naumov, Monique B Nilsson, Tina Cascone, et al.
Genome Biology|October 13, 2001
Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridolL T Lam, O K Pickeral, A C Peng, et al.
Nature Reviews. Cancer|March 31, 2019
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model dataCharles M Rudin, John T Poirier, Lauren Averett Byers, et al.
Journal of Translational Medicine|November 24, 2022
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLCCarminia Maria Della Corte, Vincenza Ciaramella, Kavya Ramkumar, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 11, 2007
Discovery of ANA975: an oral prodrug of the TLR-7 agonist isatoribineAlan X Xiang, Stephen E Webber, Bradley M Kerr, et al.
Optics Express|April 7, 2017
Lasing of surface-polished polycrystalline Ho: YAG (yttrium aluminum garnet) fiberHyunjun Kim, Randall S Hay, Sean A McDaniel, et al.
Oncotarget|February 18, 2017
Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancerC Allison Stewart, Pan Tong, Robert J Cardnell, et al.
Ebiomedicine|March 16, 2024
Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancerSehhoon Park, Tae Hee Hong, Soohyun Hwang, et al.
Molecular Cancer Therapeutics|June 10, 2010
Serum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancerLauren Averett Byers, F Christopher Holsinger, Merrill S Kies, et al.
Science (New York, N.Y.)|January 11, 2000
Strange magnetism and the anapole structure of the protonR Hasty, A M Hawthorne-Allen, T Averett, et al.
Pageof 31